Cytokinetics, Incorporated
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
3.20 |
22.29 |
164.17 |
410.14 |
940.02 |
1,458.01 |
| Przychód Δ r/r |
0.00% |
595.85% |
636.44% |
149.83% |
129.20% |
55.10% |
| Przychód (min) |
0.27 |
1.93 |
49.00 |
408.60 |
219.53 |
340.49 |
| Przychód (max) |
13.73 |
79.27 |
373.02 |
411.67 |
2,529.68 |
3,923.66 |
| EBITDA (średnia) |
-3.20 |
-22.29 |
-164.17 |
-410.14 |
-940.02 |
-1,458.01 |
| EBIT (średnia) |
-3.20 |
-22.29 |
-164.17 |
-410.14 |
-940.02 |
-1,458.01 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-615.26 |
-646.85 |
-662.55 |
-466.31 |
-60.28 |
246.35 |
| Zysk netto % |
-19205.66% |
-2901.73% |
-403.58% |
-113.70% |
-6.41% |
16.90% |
| EPS (średnia) |
-5.19 |
-5.78 |
-5.26 |
-3.50 |
-0.54 |
2.20 |
| Liczba analityków (Przychody) |
17 |
14 |
17 |
14 |
6 |
9 |
| Liczba analityków (EPS) |
16 |
14 |
15 |
13 |
9 |
11 |
| symbol |
CYTK |
CYTK |
CYTK |
CYTK |
CYTK |
CYTK |